openPR Logo
Press release

Cancer Biomarkers Market 2018 Top Profiled Companies are Becton Dickinson, Merck & Co., Agilent Technologies, Qiagen, Illumina, Affymetrix, Abbott Laboratories

07-13-2018 08:32 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Cancer Biomarkers Market

Cancer Biomarkers Market

Cancer Biomarkers Industry 2018 Global Market Research report covers a detailed study of the Global Cancer Biomarkers Market size, growth, share, trends, consumption, segments, application and Forecast 2024. This report gives you so valuable and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. It will help you to grow in the international market.

The Global Cancer Biomarkers Market has accounted to USD 10.9 billion in 2016, growing at a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 27.4 billion by 2024.

Download PDF sample copy of this research report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-biomarkers-market

Global Cancer Biomarkers Market, By Tumor (Breast, Lung, Prostate), By Type (Protein Biomarker, Genetic Biomarkers), By Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), By Application (Diagnostic, Drug Discovery, Prognostic), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

Top Competitors:

• Abbott Laboratories
• DiagnoCure Inc.
• Affymetrix, Inc.
• Illumina, Inc.
• Qiagen N.V.
• Roche Diagnostics Ltd.
• Agilent Technologies Inc.
• Quest Diagnostics Inc.
• Merck & Co. Inc.
• Hologic, Inc.
• Becton Dickinson and Company
• Among others.

To Avail 10% Discount On This Report Mail Us on:- sopan.gedam@databridgemarketresearch.com

Market Definition:

Cancer biomarkers are the molecules secreted by a tumor or a specific response of the human body indicating the presence of cancer. The biomarkers enable cancer detection at an early stage and facilitate high-speed noninvasive diagnosis using various genomics and proteomics tools. Cancer biomarkers are used for various applications such as cancer diagnostics, drug discovery and development, prognostics, personalized medicine, and surrogate endpoints. Over the years, cancer biomarkers have become an integral part of research in pharmaceutical and clinical trial companies, as they help to reduce the time and cost of the drug discovery and development process.

Factors such as rising prevalence of cancer, increasing government support for cancer biomarkers research, rising aging population, increasing use of biomarkers in the drug discovery and development process, and increasing use of biomarker tests for diagnosis purposes are fueling the growth of this market. However, poorly suited regulatory and reimbursement systems and high capital investments required for biomarker development and validation are the major factors restraining the growth of this market. Cancer biomarkers’ research and development is highly capital intensive; this is one of the key entry barriers for new players willing to enter the cancer biomarkers market. Majority of the biomarker development studies receive funding from government organizations or large pharmaceutical companies.

For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-biomarkers-market

Market Segmentation:

Based on type:

• Protein Biomarkers
• Genetic Biomarkers
• Other Biomarkers (Includes Viral, Cell, And Carbohydrate Biomarkers)

Based on cancer type:

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancers (Includes Melanoma, Leukemia, Gastric, Kidney, Liver, And Pancreatic Cancers).

By profiling technology:

• Omics Technologies
• Imaging Technologies
• Immunoassays
• Cytogenetics
• Bioinformatics

By Application:

• Diagnostic
• Drug Discovery
• Prognostic

Based on geography:

• North America
• Europe
• Asia-Pacific
• South America
• Rest Of The World

Key Questions Answered in Global Cancer Biomarkers Market Report:-

What will the market growth rate, Overview and Analysis by Type of Global Cancer Biomarkers Market in 2024?

What are the key factors driving, Analysis by Applications and Global Cancer Biomarkers Market?

What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global Cancer Biomarkers Market?

What are Opportunities, Risk and Driving Force of Global Cancer Biomarkers Market?

What are the opportunities and threats faced by the vendors in Global Cancer Biomarkers Market?

What are the Global Cancer Biomarkers Market opportunities, market risk and market overview of the Market?

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-cancer-biomarkers-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market 2018 Top Profiled Companies are Becton Dickinson, Merck & Co., Agilent Technologies, Qiagen, Illumina, Affymetrix, Abbott Laboratories here

News-ID: 1124001 • Views: 548

More Releases from Data Bridge Market Research

Tumor Ablation Market to Rise at a Highest CAGR of 13.80% With EDAP TMS, HealthT …
Data Bridge Market Research recently published Global Tumor Ablation Market study with an in-depth overview, describing the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions that are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AngioDynamics, Boston Scientific Corporation, EDAP TMS, HealthTronics, Inc., Medtronic,
Advanced Visualization Market SWOT Analysis and Forecast 2026: GENERAL ELECTRIC …
Global Advanced Visualization Market is having several developments, product launches, joint ventures, mergers and accusations by its prominent market players and top brands which are driving the market in the terms of sales, import, export, and revenue. This report gives an edge to not just compete but to outmatch the competition. The report provides with CAGR value fluctuation during the forecast period of 2018-2025 for the Advanced Visualization Market. This
Pine-Derived Chemicals Market 2019 Analysis: Eastman Chemical Company, Harima Ch …
Data Bridge Market Research recently added Global Pine-Derived Chemicals Market study with an in-depth overview, describing the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Eastman Chemical Company; Harima Chemicals Group, Inc.; Arakawa Chemical
Hair Accessories Market is Booming at a Highest CAGR of 15.29% With scünci, jdb …
Global Hair Accessories Market Research Report 2019: By Product (Clips & Pins, Head Bands, Wigs & Extensions, Elastics & Ties, Others), Material (Leather, PU, Cloth, Plastics, Metal, Others), Distribution Channel (Supermarkets & Hypermarkets, Multi-Branded Retail Stores, General Stores, Exclusive Retail, Online), End-User (Women, Men), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026 Hair Accessories Market is expected to register a healthy

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and